Bausch Health Cos Gross Margin 2010-2024 | BHC

Current and historical gross margin for Bausch Health Cos (BHC) over the last 10 years. The current gross profit margin for Bausch Health Cos as of September 30, 2024 is %.
Bausch Health Cos Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $9.47B $6.71B 70.87%
2024-06-30 $9.20B $6.52B 70.80%
2024-03-31 $8.97B $6.35B 70.81%
2023-12-31 $8.76B $6.20B 70.78%
2023-09-30 $8.54B $6.04B 70.66%
2023-06-30 $8.35B $5.88B 70.46%
2023-03-31 $8.15B $5.76B 70.61%
2022-12-31 $8.12B $5.76B 70.90%
2022-09-30 $8.13B $5.79B 71.23%
2022-06-30 $8.19B $5.86B 71.48%
2022-03-31 $8.33B $5.95B 71.52%
2021-12-31 $8.43B $6.04B 71.61%
2021-09-30 $8.45B $6.04B 71.45%
2021-06-30 $8.48B $6.06B 71.44%
2021-03-31 $8.04B $5.74B 71.35%
2020-12-31 $8.03B $5.78B 71.98%
2020-09-30 $8.04B $5.80B 72.14%
2020-06-30 $8.11B $5.88B 72.46%
2020-03-31 $8.60B $6.27B 72.87%
2019-12-31 $8.60B $6.25B 72.68%
2019-09-30 $8.50B $6.18B 72.73%
2019-06-30 $8.43B $6.11B 72.52%
2019-03-31 $8.40B $6.09B 72.44%
2018-12-31 $8.38B $6.03B 71.95%
2018-09-30 $8.42B $6.03B 71.55%
2018-06-30 $8.51B $6.03B 70.92%
2018-03-31 $8.61B $6.09B 70.67%
2017-12-31 $8.72B $6.18B 70.79%
2017-09-30 $8.96B $6.40B 71.37%
2017-06-30 $9.22B $6.66B 72.19%
2017-03-31 $9.41B $6.83B 72.62%
2016-12-31 $9.67B $7.06B 73.01%
2016-09-30 $10.03B $7.35B 73.32%
2016-06-30 $10.34B $7.67B 74.21%
2016-03-31 $10.65B $7.96B 74.71%
2015-12-31 $10.45B $7.86B 75.26%
2015-09-30 $9.91B $7.49B 75.51%
2015-06-30 $9.18B $6.84B 74.51%
2015-03-31 $8.49B $6.25B 73.62%
2014-12-31 $8.21B $5.97B 72.75%
2014-09-30 $8.05B $5.65B 70.22%
2014-06-30 $7.53B $5.12B 67.99%
2014-03-31 $6.59B $4.46B 67.76%
2013-12-31 $5.77B $3.86B 66.97%
2013-09-30 $4.63B $3.23B 69.91%
2013-06-30 $3.97B $2.92B 73.64%
2013-03-31 $3.69B $2.73B 74.05%
2012-12-31 $3.48B $2.51B 72.13%
2012-09-30 $3.21B $2.31B 71.82%
2012-06-30 $2.93B $2.09B 71.29%
2012-03-31 $2.72B $1.91B 70.42%
2011-12-31 $2.43B $1.73B 71.36%
2011-09-30 $2.29B $1.53B 66.99%
2011-06-30 $1.90B $1.25B 65.63%
2011-03-31 $1.53B $0.98B 64.24%
2010-12-31 $1.18B $0.78B 65.65%
2010-09-30 $0.91B $0.64B 70.81%
2010-06-30 $0.91B $0.66B 72.18%
2010-03-31 $0.87B $0.63B 72.58%
2009-12-31 $0.82B $0.60B 73.20%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00